Back to search resultsSummaryRMgm-4428
|
||||||||
*RMgm-4428| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene disruption |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 29307564 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Niikura M, Kobayashi F |
| Name Group/Department | Department of Infectious Diseases |
| Name Institute | Kyorin University School of Medicine |
| City | Tokyo |
| Country | Japan |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-4428 |
| Principal name | Δrap2/3 |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Parasitemia in Δrap2/3 parasite-infected mice was similar to that in control-parasite-infected mice until day 7 p.i. About 50% of B6 mice infected with Δrap2/3 parasites showed cerebral complications and died in a similar manner to mice infected with Pb ANKA at days 7-10 p.i., but approximately 40% of the mice ultimately cleared the parasites by day 60 p.i. |
| Gametocyte/Gamete | Not tested |
| Fertilization and ookinete | Not tested |
| Oocyst | Not tested |
| Sporozoite | Not tested |
| Liver stage | Not tested |
| Additional remarks phenotype | Mutant/mutation See link PBANKA_1101400 for other rap2/3 mutants (unsuccessful attempts to disrupt the rap2/3 gene and rap2/3 knock-out mutants with slow growing asexual blood stage phenotype) |
Disrupted: Mutant parasite with a disrupted gene| top of page | |||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_1101400 | ||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0501600 | ||||||||||||||||||||||||
| Gene product | rhoptry-associated protein 2 | ||||||||||||||||||||||||
| Gene product: Alternative name | rhoptry-associated protein 2/3; RAP2/3 | ||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||||||||
| Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||
| Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
| Additional remarks partial/complete disruption | |||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||
| Additional remarks genetic modification | |||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||
|
Primer information: Primers used for amplification of the target sequences
![]() Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||